10 Best Dow Dividend Stocks To Buy Right Now


Popular Posts: 5 Biotechnology Stocks to Buy Now9 “Triple A” Stocks to Buy5 Tech Services Stocks to Buy Now Recent Posts: 4 Oil and Gas Stocks to Buy Now 16 Oil and Gas Stocks to Sell Now 5 Machinery Stocks to Buy Now View All Posts

This week, 12 stocks get F’s (“strong sell”) in Portfolio Grader‘s three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.


These are the worst of the worst in the entire Portfolio Grader database. This week, there are 4,328 stocks and only these 12 get failing marks in all categories to make the dreaded “Triple F” stocks list. Here they are:

10 Best Dow Dividend Stocks To Buy Right Now: Arrowhead Research Corporation(ARWR)

Arrowhead Research Corporation, a clinical stage nanomedicine company, through its subsidiaries, develops therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. It focuses on the design and development of therapeutic agents for the treatment of cancer and obesity, as well as healing wounded or diseased tissue based on nucleic acid delivery, siRNA chemistry, and tissue targeting intellectual properties. The company?s lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism; and Adipotide, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. It also plans to develop its internal preclinical and clinical pipeline, including RONDEL-enabled siRNA drug candidates, Dynamic Polyconjugate (DPC)-enabled drug candidate development, and the non-siRNA-based anti-obesity drug candidate, Adipotide. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.


Advisors’ Opinion:

  • [By Bryan Murphy]

    A week ago, yours truly recommended adding EnteroMedics Inc. (NASDAQ:ETRM), Arrowhead Research Corp. (NASDAQ:ARWR), and Celldex Therapeutics, Inc. (NASDAQ:CLDX) to your watchlist, all as bullish candidates. Although ETRM was a bust, CLDX and ARWR are both still compelling. In fact, those two survivors merit an updated look, as each has moved further along its bullish path, and each looks like it’s itching to put the pedal to the metal.

  • [By Bryan Murphy]

    If you’re looking to get the new trading year started on the right foot, then you may want to keep Celldex Therapeutics, Inc. (NASDAQ:CLDX), EnteroMedics Inc. (NASDAQ:ETRM), and Arrowhead Research Corp. (NASDAQ:ARWR) in your back pocket if not in your portfolio. Why? Because these three small cap stocks are positioned to deliver big breakouts, if they’re not already doing so. Here’s a closer look at each, and exactly what you need to watch for with CLDX, ARWR, and ETRM.

  • [By John Udovich]

    Small cap hepatitis stock Achillion Pharmaceuticals, Inc (NASDAQ: ACHN) saw shares jump on Monday only to then have a minor implosion on Tuesday – meaning its worth taking a look at that hiccup and the history of hiccups or successes from other small cap hepatitis stocks like Idenix Pharmaceuticals Inc (NASDAQ: IDIX), Arrowhead Research Corp (NASDAQ: ARWR) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY). It should be mentioned that Hepatitis A, B and C are viral infections that together affect an estimated 5% to 6% of Americans and while globally, 2 billion people (1 out of 3 people) have been infected with hepatitis B with  400 million people chronically infected plus 130–150 million people have chronic hepatitis C – meaning there is plenty of room for large and small cap players alike in the space.

  • [By Bryan Murphy]

    While the overall market still seems to be figuring out whether it can move any higher in its current overbought state, a handful of names has already figured out they’ve got plenty of room to keep advancing now that they’ve gotten the ball rolling again. Among the best of the best are China Hgs Real Estate Inc. (NASDAQ:HGSH), Arrowhead Research Corp. (NASDAQ:ARWR), and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Here’s a closer look at each, and why each has some technical upside on front of it.

10 Best Dow Dividend Stocks To Buy Right Now: Altera Corporation (ALTR)


Altera Corporation, a semiconductor company, designs, manufactures, and markets programmable logic devices (PLD), HardCopy application-specific integrated circuit (ASIC) devices, pre-defined design building blocks, and associated development tools. Its PLDs consist of field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs), which are semiconductor integrated circuits manufactured as standard chips that can be programmed to perform logic functions in electronic systems; and HardCopy structured ASIC devices that transition customer designs from high-density FPGAs to low-cost non-programmable implementations for volume production. The company?s products primarily include Stratix series high-end, system-level FPGAs; Arria series mid-range, transceiver-equipped FPGAs; Cyclone series low-cost FPGAs; MAX series CPLDs; and HardCopy ASICs. It also offers intellectual property cores that are pre-verified building blocks that execute system-level functio ns that is incorporated into the PLD design; and development tools consisting primarily of the Quartus II software for design entry, design compilation, design verification, and device programming. Altera Corporation serves customers primarily in the telecom and wireless, industrial automation, military and automotive, networking, and computer and storage markets. The company markets its products through a network of distributors, independent sales representatives, and direct sales personnel. It has operations in the Americas, the Asia Pacific, Europe, the Middle East, Africa, and Japan. The company was founded in 1983 and is headquartered in San Jose, California.


Advisors’ Opinion:

  • [By ovenerio]

    Logic devices can be divided as well into two categories, fixed and programmable. The programmable logic market, or PLD, is led by Xilinx and Altera Corporation (ALTR). PLD chips have the characteristic that can be programmed, so electronics manufacturers’ instructions can be more easily reprogrammed and can customize their circuitries for specific applications.

  • [By amal.singh70]

    Altera (ALTR) posted decent results. The programmable chip maker came out with good numbers, topping analysts’ estimates on earnings and revenue. Further, in line with good results, Altera is expecting better results in the future.

10 Best Dow Dividend Stocks To Buy Right Now: Sony Corp Ord(SNE)


Sony Corporation designs, develops, manufactures, and sells electronic equipment, instruments, and devices for consumer, professional, and industrial markets worldwide. The company offers consumer products and devices, including televisions, video cameras, compact digital cameras and interchangeable single-lens cameras, Blu-ray Disc players/recorders, DVD-video players/recorders, home theaters and audio systems, and portable audio and car audio products. It also provides charged coupled devices, complementary metal-oxide semiconductor image sensors, system LSIs, small- and medium-sized LCD panels, and other semiconductors; and components, such as batteries, optical disk drives, chemical products, audio/video/data recording media, storage media, and optical pickups. In addition, the company develops, produces, markets, and distributes games, such as PlayStation3, PlayStation Portable, and PlayStation 2 hardware and related software; and PCs and flash memory digital audio pl ayers, as well as manufactures broadcast- and professional-use products, Blu-ray discs, DVDs, and CD discs. Further, it produces and distributes motion pictures and television programs, and home entertainment; creates and distributes digital content; operates television networks and studio facilities; and develops entertainment products, services, and technologies. Additionally, the company engages in the music publishing business, as well as provision of various financial services, including insurance, savings products, loans, and credit financing services; and a network service business and an advertising agency business. It also involves in research, development, design, production, marketing, sales, distribution, and servicing mobile phones, accessories, services, and applications. The company was formerly known as Tokyo Tsushin Kogyo Kabushiki Kaisha and changed its name to Sony Corporation in 1958. Sony Corporation was founded in 1946 and is based in Tokyo, Japan.


Advisors’ Opinion:

  • [By Brian Stelter]

    The controversial Seth Rogen comedy has been rented or purchased a total of 4.3 million times since its online release on Christmas Eve, Sony (SNE) said Tuesday.

  • [By Steve Symington]

    Take heart, Spidey fans. Your favorite web-slinging superhero may still be in line to receive the proper big-screen treatment he deserves. In this case, that could be a huge catalyst for investors in both Sony (NYSE: SNE  ) and The Walt Disney Company (NYSE: DIS  ) .

  • [By Frank Pallotta]

    “The Interview” was first distributed online last week through streaming services like YouTube and Google (GOOG)Play. By expanding to cable and satellite audiences, Sony (SNE) will bring the movie to more homes, including those that aren’t online.

10 Best Dow Dividend Stocks To Buy Right Now: Progress Software Corporation(PRGS)

Progress Software Corporation operates as an enterprise software company worldwide. Its products include Progress OpenEdge platform, which offers development tools, application servers, application management tools, and an embedded database; Progress Orbix to address enterprise integration problems with standards-based solutions; and Progress ObjectStore, an object data management system to store data faster than relational database management system or file-based storage system. The company?s products also comprise Progress Responsiveness Process Management suite for business users; Progress Control Tower, an interactive business control panel; Progress Sonic, which comprises an enterprise messaging system and the enterprise service buses; Progress Actional that provides operational and business visibility, root cause analysis, and policy-based security and control of services; Progress Apama, which offers tools for creating, testing, and deploying strategies for applicat ions, including algorithmic trading, market aggregation, smart order routing, market surveillance and monitoring, and risk management; Progress Savvion BusinessManager, a business process management software; and Fuse products that provide customers with access to professional open source integration and messaging software. In addition, it offers Progress DataDirect Connect products, which provide data connectivity components; Progress DataDirect Shadow to provide foundation architecture for standards-based mainframe integration; and Progress Data Services product set that offers data integration for distributed applications. Further, the company provides maintenance, consulting, training, and customer support services. Progress Software Corporation sells its products to independent software vendors, original equipment manufacturers, and system integrators through direct sales force and independent distributors. The company was founded in 1981 and is based in Bedford, Massa c husetts.


Advisors’ Opinion:

  • [By Garrett Cook]

    In trading on Friday, technology shares were relative leaders, up on the day by about 0.31 percent. Top gainers in the sector included Aware (NASDAQ: AWRE), up 15.4 percent, and Progress Software (NASDAQ: PRGS), up 7.7 percent.

  • [By Garrett Cook]

    In trading on Friday, technology shares were relative leaders, up on the day by about 0.31 percent. Top gainers in the sector included Aware (NASDAQ: AWRE), up 15.4 percent, and Progress Software (NASDAQ: PRGS), up 7.7 percent.

  • [By Garrett Cook]

    In trading on Friday, technology shares were relative leaders, up on the day by about 0.15 percent. Top gainers in the sector included Aware (NASDAQ: AWRE), up 15.9 percent, and Progress Software (NASDAQ: PRGS), up 10.5 percent.

  • [By John Kell and Lauren Pollock var popups = dojo.query(“.socialByline .popC”); ]

    Progress Software Corp.’s(PRGS) fiscal first-quarter profit fell 64% as the business-software provider’s revenue slipped due to the timing of certain deal closures.

10 Best Dow Dividend Stocks To Buy Right Now: Addus HomeCare Corporation(ADUS)


Addus HomeCare Corporation provides a range of social and medical services to individuals in the home. The company serves individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill, and disabled. It offers various health services that include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. The company?s Home and Community Services division offers assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living on a long-term, continuous basis, with an average duration of 20 months per consumer. Its Home Health Services division comprises physical, occupational, and speech therapy, as well as skilled nursing services, which are offered on a short-term, intermittent, or episodic basis to individuals recovering from an acute medical condition, with an average length of c are of 80 days. The company?s payor clients include federal, state, and local government programs, such as Medicaid funded programs and Medicaid waiver programs; other state agencies and Medicare; and the Veterans Health Administration, commercial insurers, and private duty consumers. The company was formerly known as Addus Holding Corporation and changed its name to Addus HomeCare Corporation in September, 2006. Addus HomeCare Corporation was incorporated in 2006 and is headquartered in Palatine, Illinois.


Advisors’ Opinion:

  • [By Monica Gerson]

    Addus HomeCare (NASDAQ: ADUS) is projected to post its Q4 earnings at $0.25 per share on revenue of $68.07 million.

    magicJack VocalTec (NASDAQ: CALL) is expected to post its Q4 earnings at $0.41 per share on revenue of $35.93 million.

10 Best Dow Dividend Stocks To Buy Right Now: Versar Inc. (VSR)

Versar, Inc. operates as a project management company in the United States and internationally. The company operates through three segments: Engineering and Construction Management, Environmental Services, and Professional Services. The Engineering and Construction Management segment offers project scoping/development, design, cost estimation, value engineering, and feasibility studies; construction oversight, configuration management, inspection, job site evaluations, and construction documentation; system optimization, scheduling, and quality assurance/control; and construction services to federal, state, local, international, and commercial clients. The Environmental Services segment offers environmental solutions, such as remediation and compliance, exposure, and risk assessment; natural resources; unexploded ordnance cleanup/military munitions response programs; and air, greenhouse gas, energy, and cultural resources services to various federal and state agencies. Th e Professional Services segment provides onsite environmental management, planning, and engineering services to DoD installations and to the U.S. Department of Commerce. This segment’s services include energy, waste, and water services; cleaning of landfill and disposal sites; facility and utilities integration, water program management, and wildlife program management; management of hazardous materials and waste for generator sites; staff augmentation; and biological and physical sciences support services. The company also provides engineering design, construction management, environmental planning and programming, and other services for various government, industry, and commercial clients. Versar, Inc. was founded in 1969 and is headquartered in Springfield, Virginia.


Advisors’ Opinion:

  • [By John Udovich]

    Small cap stocks Versar Inc (NYSEMKT: VSR), Ecology and Environment, Inc (NASDAQ: EEI) and CES Synergies Inc (OTCBB: CESX) provide various environmental, technical, management and related services to government and private sector clients. And while a GOP controlled congress may limit the growth of government spending, the private sector will still need to comply with increasingly onerous environmental and other regulations coming from the government. Moreover, an improving economy will lead to more construction and engineering work along with the need for various environmental and remediation services. With those thoughts in mind, here is what you need to know about all three small cap environmental services stocks:

10 Best Dow Dividend Stocks To Buy Right Now: Saia Inc.(SAIA)


Saia, Inc., an asset-based trucking company, provides transportation and supply chain solutions primarily to the retail, chemical, and manufacturing industries in the United States. The company, through it subsidiary, Saia Motor Freight Line, LLC, offers regional and interregional less than truckload (LTL) services, selected national LTL, and time-definite services. It was formerly known as SCS Transportation, Inc. Saia, Inc. was founded in 2000 and is headquartered in Johns Creek, Georgia.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Wunderlich’s Nicholas Bender thinks FedEx’s results bode well for Old Dominion (ODFL), Con-way (CNW) and Saia (SAIA):

    We expect all less-than-truckload carriers to benefit in 2Q14 from the same trends that carried FedEx Freight to a banner 4Q14. This includes Hold-rated Old Dominion, which will continue to grow at well above market rates, and Buy-rated Con-way, which we believe can leverage a strong 2Q14 to prime the pump on margin enhancement efforts. Our favorite name in the space remains Saia (SAIA-$42.92, Buy), which will once again see accelerating tonnage growth in 2Q14. Though tonnage growth will moderate in  2H14 due to steeper comps, there remains considerable potential for the company to boost yield and continue winning incremental business with new accounts.

  • [By John Udovich]

    Despite what can best be described as a soft economy, small cap trucking stocks YRC Worldwide, Inc (NASDAQ: YRCW), Arkansas Best Corporation (NASDAQ: ABFS), Frozen Food Express Industries, Inc (NASDAQ: FFEX), Saia Inc (NASDAQ: SAIA) and USA Truck, Inc (NASDAQ: USAK) have been trucking some pretty impressive returns since the start of the year. In fact, these small cap trucking stocks are up anywhere from 72% to 150% or so since the start of the year despite the slow economy. Certainly trucking stocks provide a good indicator of how the economy is doing, but might investors be jumping the gun by pushing up these trucking stocks?

10 Best Dow Dividend Stocks To Buy Right Now: Titan Pharmaceuticals Inc (TTNP)


Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson’s disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson’s disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.


Probuphine

Probuphine is the first product to utilize the Company’s ProNeura long-term d rug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.


Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ilop! eridone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.


Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company’s cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated with h uman retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson’s disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson’s disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson’s disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson’s disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.


Bayer Schering, the Company’s corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide develop ment, manufacturing and commercialization rights, and, in ad! dition to! the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors’ Opinion:

  • [By CRWE]

    Today, TTNP surged (+2.76%) up +0.018 at $.689 with 152,996 shares in play thus far (ref. google finance Delayed: 2:02PM EDT October 1, 2013).


    Titan Pharmaceuticals, Inc. previously reported that the U.S. Food and Drug Administration (FDA) has granted the request for a meeting to discuss Probuphine®. The meeting is scheduled for November 19, 2013. The FDA has designated this as a Type C meeting and has requested the submission of briefing materials by October 7, 2013.

10 Best Dow Dividend Stocks To Buy Right Now: The Dixie Group Inc.(DXYN)

The Dixie Group, Inc. engages in the manufacture, marketing, and sale of carpets and rugs to residential and commercial customers primarily in the United States. It also offers broadloom and modular carpets for the specified commercial marketplace. The company sells its products under the Fabrica International, Masland Carpets, and the Dixie Home brands. It also processes yarns, and provides carpet dyeing and finishing services to other carpet manufacturers. The company primarily serves interior decorators and designers, selected retailers and furniture stores, luxury home builders, and manufacturers of luxury motor coaches and yachts. The Dixie Group, Inc. was founded in 1920 and is based in Chattanooga, Tennessee.


Advisors’ Opinion:

  • [By Roberto Pedone]

    Dixie Group (DXYN) markets, manufactures and sells carpet and rugs to high-end residential and commercial customers through its various sales forces and brands. This stock closed up 10.9% at $11.48 in Thursday’s trading session.

    Thursday’s Volume: 218,000

    Three-Month Average Volume: 82,425

    Volume % Change: 198%

    From a technical perspective, DXYN ripped sharply higher here right above some near-term support around $10 with strong upside volume. This stock has been trending sideways inside of a consolidation pattern for the last month, with shares trending between $10 on the downside and $12.05 on the upside. This consolidation pattern is occurring after a strong uptrend for shares of DXYN, which took the stock from $4.99 in March to $10 in August. This spike is now starting to push shares of DXYN within range of triggering a big breakout trade. That trade will hit if DXYN manages to take out Thursday’s intraday high at $11.99 and then once it clears its 52-week high at $12.05 with high volume.


    Traders should now look for long-biased trades in DXYN as long as it’s trending above $11 or Thursday’s low of $10.43, and then once it sustains a move or close above those breakout levels with volume that hits near or above 82,425 shares. If that breakout triggers soon, then DXYN will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

  • [By David Goodboy]

    The company I discovered astounded me: It's up more than 220% in the past year, and shares are trading for around $11. It is high-end carpet maker The Dixie Group (Nasdaq: DXYN). Founded in 1919, this carpet manufacturer and marketing company has a market cap of about $143 million and annual revenue of just over $296 million. It sells carpets with the Fabrica International, Masland Residential and Dixie Home brands. 

10 Best Dow Dividend Stocks To Buy Right Now: Harte-Hanks Inc. (HHS)

Harte-Hanks, Inc., a direct and targeted marketing company, provides multichannel direct and digital marketing services, and shopper advertising opportunities to a range of local, regional, national, and international consumer and business-to-business marketers in the United States and other countries. It offers integrated, multichannel, and data-driven solutions for various brands to retail, high-tech/telecom, financial services, and pharmaceutical/healthcare markets. The company provides agency and digital services, including Website development and design, digital strategy, social media marketing and monitoring, email marketing, and ecommerce and interactive relationship management services; database marketing solutions that enable organizations to build and manage customer communication strategies; and Trillium Software System, a global locator geocoding product, as well as associated data governance services. It also offers direct mail and fulfillment, and business-to -business lead generation services, as well as operates teleservice workstations that provide advanced contact center solutions. The company has a strategic partnership with GX Software. Harte-Hanks, Inc. was founded in 1970 and is headquartered in San Antonio, Texas.

Advisors’ Opinion:

  • [By Eric Volkman]

    There will soon be a new moniker on the CEO nameplate at Harte-Hanks (NYSE: HHS  ) . The company has picked Robert Philpott to replace outgoing Chief Executive Larry Franklin, who will retire on June 30. Philpott, who was selected following a global search led by a board of directors committee, will also assume Franklin’s role as president of the company.

  • [By Luke Jacobi]

    Harte-Hanks (NYSE: HHS) shot up 6.76 percent to $8.53 after BMO Capital upgraded the stock from Market Perform to Outperform.

    Facebook (NASDAQ: FB) gained 3.78 percent to $51.04. Facebook’s Instagram reported that it will introduce advertisements in the coming months. Sterne Agee raised the price target on the stock from $50.00 to $58.00.